These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18045697)

  • 1. IgA1 desialylated by microbial neuraminidase forms immune complex with naturally occurring anti-T antibody in human serum.
    Anuradha ; Jayakumari N; Appukuttan PS
    Immunol Lett; 2008 Jan; 115(2):90-7. PubMed ID: 18045697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1-->3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand.
    Sangeetha SR; Appukuttan PS
    Int J Biol Macromol; 2005 Jun; 35(5):269-76. PubMed ID: 15862866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High polymeric IgA content facilitates recognition of microbial polysaccharide-natural serum antibody immune complexes by immobilized human galectin-1.
    Paul A; Antony M; Mathai J; Appukuttan PS
    Immunol Lett; 2011 Apr; 136(1):55-60. PubMed ID: 21147166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients.
    Iwase H; Katsumata T; Itoh A; Hiki Y; Ikuko N; Sano T; Takatani T; Kobayashi Y
    J Nephrol; 2002; 15(6):703-8. PubMed ID: 12495288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A; Monteiro R; Coppo R
    G Ital Nefrol; 2006; 23(3):313-22. PubMed ID: 16868911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD.
    Rudd PM; Fortune F; Patel T; Parekh RB; Dwek RA; Lehner T
    Immunology; 1994 Sep; 83(1):99-106. PubMed ID: 7821975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.
    Bray J; Lemieux RU; McPherson TA
    J Immunol; 1981 May; 126(5):1966-9. PubMed ID: 7217675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology of desialylation: human plasma lipoprotein(a) and circulating anti-carbohydrate antibodies form immune complexes that recognize host cells.
    Sabarinath PS; Appukuttan PS
    Mol Cell Biochem; 2015 May; 403(1-2):13-23. PubMed ID: 25633186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
    Springer GF; Desai PR
    Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
    Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
    J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
    Almogren A; Kerr MA
    Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerular response to IgA deposition in IgA nephropathy.
    Moura IC; Benhamou M; Launay P; Vrtovsnik F; Blank U; Monteiro RC
    Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells.
    Zhang JJ; Xu LX; Zhang Y; Zhao MH
    Clin Immunol; 2006 Apr; 119(1):103-9. PubMed ID: 16442846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Binding capacity of aberrantly glycosylated serum IgA1 with human umbilical vein endothelial cells].
    Zhang JJ; Yu F; Xu LX; Zhang Y; Zhao MH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):139-42. PubMed ID: 15841140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.